SIXTY-FOURTH LEGISLATURE OF THE STATE OF WYOMING 2017 GENERAL SESSION

Similar documents
SENATE FILE NO. SF0042. Sponsored by: Joint Judiciary Interim Committee A BILL. for. AN ACT relating to public health and safety; creating the

[First Reprint] ASSEMBLY, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 4, 2016

ASSEMBLY, No. 542 STATE OF NEW JERSEY. 218th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2018 SESSION

PROPOSED AMENDMENTS TO HOUSE BILL 3440

SIXTY-FOURTH LEGISLATURE OF THE STATE OF WYOMING 2017 GENERAL SESSION

3 By Representatives Sells, Weaver, Harper, South, McCutcheon, 4 Harbison, Butler, Mooney, Hanes, Williams (JW), Wilcox, Scott,

SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2217

Sub. S.B. 119 As Passed by the Senate

Good Samaritan and Naloxone Bill Status Report Carryover 2015 and Special Sessions

ASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED MAY 15, 2014

Referred to Committee on Health and Human Services. SUMMARY Establishes an opioid overdose prevention policy for Nevada.

A Bill Regular Session, 2015 SENATE BILL 880

R ADMINISTERING AN OPIOID ANTIDOTE. B. Acquisition, Maintenance, Accessibility, and Documentation of an Opioid Antidote

THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL

Naloxone Access Statutes

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0

Naloxone Access Statutes

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

CRITICAL POLICY REFERENCE MANUAL FILE CODE: X Monitored X Mandated Sample Policy X Other Reasons

Public Health Impacts of 2016 West Virginia Legislation

A Bill Regular Session, 2015 SENATE BILL 717

Be it enacted by the People of the State of Illinois,

Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016.

Good Samaritan and Naloxone Bill Status Report Carryover 2016 and Special Sessions

Good Samaritan and Naloxone Bill Status Report Carryover 2015 and Special Sessions

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW HOUSE BILL 243

1 SB By Senator Sanford. 4 RFD: Judiciary. 5 First Read: 14-JAN-14. Page 0

SUMMARY Provides for the award of certain grants relating to the prevention and treatment

Michigan Opioid Legislation Hospital Compliance Checklist

Secretary of the Senate. Chief Clerk of the Assembly. Private Secretary of the Governor

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 3440

Secretary of the Senate. Chief Clerk of the Assembly. Private Secretary of the Governor

2016 Dr. Douglas H. Kay CPE Symposium

Dispensing and administration of emergency opioid antagonist without a

CHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 2760

ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM. [ NMAC - N, ; A, ]

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

FL AT Act As amended 5/30/06 by Chapter (SB 366) (Amendments not noted; see SB 366 file for changes) PART XIII ATHLETIC TRAINERS

PRODUCTS: All products containing ephedrine (EPH) and pseudoephedrine (PSE). (IC )

As Passed by the House. Regular Session H. B. No

Request for Proposal. PA ACT 139 Naloxone Purchase

TWELFTH NORTHERN MARIANAS COMMONWEALTH LEGISLATURE Public Law THIRD REGULAR SESSION, 2001 H. B. NO AN ACT

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS

H 7816 S T A T E O F R H O D E I S L A N D

11 FEB 2016 COMMONWEALTH OF THE NORTHERN MARIANA ISLANDS. Victor B. Hocog Lieutenant Governor. Ralph DLG. Torres Governor

[CORRECTED COPY] CHAPTER 115

CHAPTER House Bill No. 1429

As Passed by the House. Regular Session Sub. H. B. No

Clinical Policy: Naloxone (Evzio) Reference Number: CP.PMN.139 Effective Date: Last Review Date: Line of Business: Commercial, Medicaid

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION

10/20/14& the administration of nasal naloxone by school nurses. for nasal naloxone

NC General Statutes - Chapter 90 Article 5E 1

SENATE, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 8, 2016

Temple University Beasley School of Law. Project on Harm Reduction in the Health Care System

btute PUBLIC CHAPTER NO. 1039

First Regular Session Seventy-first General Assembly STATE OF COLORADO INTRODUCED SENATE SPONSORSHIP HOUSE SPONSORSHIP

SENATE BILL No As Amended by Senate Committee

ORDINANCE NO. City Attorney s Synopsis

Illinois Supreme Court. Language Access Policy

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

SUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014

Legislative Bill Watch As of Thursday March, 13, 2014

Senate Bill No. 459 Committee on Health and Human Services

Florida Senate SB 224

Model Intervention for Students with Substance Abuse Problems Act

UTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB)

CHAPTER NINE INSULIN AND GLUCAGON ADMINISTRATION

CHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 1030

Objectives 1/25/18. An Update on Controlled Substance Prescribing Laws & Rules for CNMs. Exclusionary Formulary Effective: May 17, 2017

Oklahoma Statutes on Prevention of Youth Access to Tobacco

SECTION PRESCRIPTIONS

The State of Maryland Executive Department

Title 32: PROFESSIONS AND OCCUPATIONS

Senate Bill No. 481 Committee on Health and Human Services

For An Act To Be Entitled. Subtitle

DHEC Bureau of EMS DAODAS

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

California. Prescribing and Dispensing Profile. Research current through November 2015.

Act 443 of 2009 House Bill 1379

ORDINANCE NO

& CONSUMES 80% 5% OF THE WORLD S POPULATION 5/19/2017. New Naloxone Regulations & the Importance of Using PRESCRIPTION DRUG ABUSE EPIDEMIC

TENNESSEE: PROPOSED REGULATION OF DIAGNOSTIC MEDICAL SONOGRAPHERS

B. The intent of the CUA was to enable persons in the State of California who

ORDINANCE NO SECTION 1. The Board of Supervisors makes the following findings in support of this ordinance:

Be it enacted by the General Assembly of the State of Colorado:

States with Authority to Require Nonresident Pharmacies to Report to PMP

Legal Considerations for. Immunizations

OPIOID EMERGENCY RESPONSE REGULATION

SELF-ADMINISTERED MEDICATION AND EPINEPHRINE USE

VERIFICATION OF VOLUNTARY DONATION FOR HUMAN EMBRYONIC STEM CELL RESEARCH

HOW DOES THE STOP ACT IMPACT YOU?

Lobbyist-in-a-Box: (VPhAT) created on 01/15 at 10:11

ORDINANCE NO REZONE NO. 213

ORDINANCE NO The Town Council of the Town of Yucca Valley, California, ( Town ) does ordain as follows:

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

Project on Harm Reduction in the Health Care System

AN ACT RELATING TO HEALTH CARE; ENACTING THE UNLICENSED HEALTH CARE BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:

S 0332 S T A T E O F R H O D E I S L A N D

Transcription:

AN ACT relating to public health and safety; creating the Emergency Administration of Opiate Antagonist Act; providing for prescription and administration of an opiate antagonist drug as specified; granting immunity from criminal or civil liability for specified conduct; providing rulemaking authority; and providing for an effective date. Be It Enacted by the Legislature of the State of Wyoming: Section 1. W.S. 33-24-158 and 35-4-901 through 35-4-906 are created to read: 33-24-158. Prescription of opiate antagonist by pharmacist. (a) A pharmacist licensed under this act may prescribe an opiate antagonist in accordance with the Emergency Administration of Opiate Antagonist Act. (b) The board, in cooperation with the Wyoming state board of medicine, shall adopt rules specifying the requirements a pharmacist shall meet in order to prescribe an opiate antagonist. ARTICLE 9 EMERGENCY ADMINISTRATION OF OPIATE ANTAGONIST ACT 35-4-901. Short title. This article may be cited as the "Emergency Administration of Opiate Antagonist Act." 35-4-902. Definitions. 1

(a) As used in this article: (i) "Opiate antagonist" means naloxone hydrochloride, narcan or any other brand name used for naloxone hydrochloride approved by the United States food and drug administration for the treatment of an opiate related drug overdose; (ii) "Opiate related drug overdose" means a condition, including extreme physical illness, a decreased level of consciousness or respiratory depression resulting from the consumption or use of an opioid, or another substance with which an opioid was combined, that a reasonable person would believe to require medical assistance; (iii) "Pharmacist" means any person licensed under Wyoming statutes as a pharmacist and who is practicing within the scope of their license; (iv) "Practitioner" means any person licensed under Wyoming statutes as a physician, physician assistant or advanced practice registered nurse and who is practicing within the scope of their license; (v) "Standing order" means an order transmitted electronically or in writing by a practitioner for a drug or device for a patient or multiple patients with whom no prescriber-patient relationship exists. 35-4-903. Prescription of opiate antagonist. (a) A practitioner or a pharmacist acting in good faith and exercising reasonable care may, without a 2

prescriber-patient relationship, prescribe an opiate antagonist to: (i) A person at risk of experiencing an opiate related drug overdose; (ii) A person in a position to assist a person at risk of experiencing an opiate related drug overdose; (iii) A person who, in the course of the person's official duties or business, may encounter a person experiencing an opiate related drug overdose. (b) A practitioner or pharmacist who prescribes an opiate antagonist under this article shall provide education to the person to whom the opiate antagonist is prescribed, which shall include written instruction on how to: (i) Recognize an opiate related drug overdose; (ii) Respond appropriately to an opiate related drug overdose event, including how to administer an opiate antagonist; (iii) Ensure that a person to whom an opiate antagonist has been administered receives, as soon as possible, additional medical care and a medical evaluation. 35-4-904. Standing order for opiate antagonist; drug overdose treatment policy; rules. (a) A practitioner acting in good faith and exercising reasonable care may prescribe by a standing order an opiate antagonist to an entity that, in the course 3

of the entity's official duties or business, may be in a position to assist a person experiencing an opiate related drug overdose. (b) An entity prescribed an opiate antagonist by standing order shall establish a drug overdose treatment policy in accordance with rules adopted by the department of health. The drug overdose treatment policy shall: (i) Provide for the designation of individuals to receive training and instructional materials on how to recognize and respond to an opiate related drug overdose and ensure that a person to whom an opiate antagonist has been administered receives additional medical care and a medical evaluation; (ii) Provide for reporting to the department of health, in the manner and form prescribed by the department, all opiate related drug overdoses for which an opiate antagonist is administered. (c) The Wyoming state board of medicine and the Wyoming state board of nursing may adopt rules as necessary to implement and administer prescription of an opiate antagonist by a standing order. 35-4-905. Voluntary participation. This article does not establish a duty or standard of care for a person to prescribe or administer an opiate antagonist. 35-4-906. Administration of an opiate antagonist; immunity from liability; exemption from unprofessional conduct; relation to other law. 4

(a) A person acting in good faith may administer an opiate antagonist to another person who appears to be experiencing an opiate related drug overdose. (b) A person who administers an opiate antagonist pursuant to this article is personally immune from civil or criminal liability for any act or omission resulting in damage or injury. (c) A practitioner or pharmacist who prescribes an opiate antagonist pursuant to this article is personally immune from civil or criminal liability for any act or omission resulting in damage or injury. (d) An entity that establishes a drug overdose treatment policy pursuant to this article is immune from civil or criminal liability for any act or omission related to the administration of an opiate antagonist resulting in damage or injury. (e) Prescribing an opiate antagonist by a practitioner or pharmacist pursuant to this article shall not constitute unprofessional conduct. (f) Should any grant of immunity, exception or imposition of liability within the Wyoming Governmental Claims Act conflict with any provision of this article, this article shall prevail. 5

Section 2. This act is effective July 1, 2017. (END) Speaker of the House President of the Senate Governor TIME APPROVED: DATE APPROVED: I hereby certify that this act originated in the Senate. Chief Clerk 6